Feb 18, 2021Anavex Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Jan 11, 2021Anavex Life Sciences Receives Michael J. Fox Foundation Grant for Clinical Study of ANAVEX®2-73
Dec 22, 2020Anavex Life Sciences to Announce Fiscal 2020 Year End Financial Results December 28th, 2020
Dec 21, 2020Anavex Life Sciences Announces Webinar on Rett Syndrome and ANAVEX®2-73 (Blarcamesine) Phase 2 Data
Aug 5, 2020Anavex Life Sciences Reports Fiscal 2020 3rd Quarter Financial Results And Provides Business Updates
May 7, 2020Anavex Life Sciences Reports Fiscal 2020 2nd Quarter Financial Results And Provides Business Updates
Jan 30, 2020Anavex Life Sciences to Announce Fiscal 2020 First Quarter Financial Results on Thursday, 2/6/2020
Dec 16, 2019Anavex Life Sciences Reports Fiscal Year 2019 Financial Results And Provides Clinical Study Update
Dec 10, 2019Anavex Life Sciences to Announce Fiscal 2019 Year End Financial Resultson Monday December 16, 2019
Dec 4, 2019Anavex Life Sciences Presents ANAVEX®2-73 Data at 12th Clinical Trials on CTAD 2019 Conference
Sep 25, 2019Anavex Life Sciences to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
